What is Multiple Myeloma?4
Multiple myeloma is a type of blood cancer that affects plasma cells. In multiple myeloma, malignant plasma cells accumulate in the bone marrow (the soft, spongy tissue at the center of your bones), crowding out the normal plasma cells that help fight infection. These malignant plasma cells then produce an abnormal antibody called M protein, which offers no benefit to the body and may cause tumors, kidney damage, bone destruction, and impaired immune function. The hallmark characteristic of multiple myeloma is a high level of M protein in the blood.
Multiple myeloma typically displays the most activity in bone marrow, which includes the marrow in the spine, pelvic bones, ribs, shoulders, and hips.
Symptoms of Multiple Myeloma5
Multiple Myeloma is often a slow-developing disease and in the early stages, a person may not exhibit symptoms at all. However, as the disease reaches advanced stages, the following symptoms may appear:
- Fatigue, weakness
- Shortness of breath
- Weight loss
- Bone pain (most frequently in the back or ribs)
- Bone fractures (usually in the spine) without explanation
Multiple Myeloma Treatment Options6
Treatment options vary widely and are based upon whether the patient is experiencing symptoms, their overall health, and what stage the patient is in. A patient’s doctor and/or care team will work with patients to decide the best way to move forward with treatment so that the cancer can be managed successfully for many years. For more information on the varying types of treatment for patients, please visit www.cancer.net - the doctor-approved patient information site from ASCO.
What Patients and Caregivers Should Know About Clinical Studies for Multiple Myeloma
According to the Multiple Myeloma Research Foundation website, almost all cancer treatments available today resulted from research conducted in clinical trials. Clinical trials are vital to the development and creation of new multiple myeloma treatments, and to helping patients and doctors understand more about this rare and complex blood cancer. For many people with multiple myeloma, participation in a clinical trial may be a good option for treatment. If you are considering participating in a clinical trial, speak with your treatment team about which trial might be the best option for you or if standard treatment options may be a better choice at that point in time.
For more information about Cellectar Biosciences’ clinical studies for multiple myeloma, please visit: https://www.cellectar.com/clinical-studies.
Additional Resources for Patients and Caregivers Affected by Multiple Myeloma
Housing and Travel Assistance
Resources, Organizations, and Support